“sorafenib” Archives

in
Entry Author Date Location
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Inspyr Leaves San Antonio for California to Be Near Clinical Trials 10/12/16 Texas
Inspyr Seeks Clinical Partner for Cash After New Name, Exec Hires 08/09/16 Texas
Early Stage San Antonio Drug Trial Firm START Opens Taiwan Outpost 05/20/16 Texas
Aveo, Still Breathing, Cuts New Deal With Novartis 08/17/15 Boston
After Spinning Onyx into Gold, Coles Returns to Lead a CNS Startup 12/15/14 Boston
GenSpera’s Targeted “Death Carrot” Toxin in Trials for Two Cancers 03/27/14 Texas
SEC Comes Calling For Aveo As FDA Panel Fallout Continues 07/11/13 Boston
FDA Declines To Approve Aveo’s Drug For Kidney Cancer 06/10/13 Boston
Astellas Tells Aveo to Go It Alone in Kidney Cancer 05/24/13 Boston
Lessons For Drug Development From The Aveo Buzzsaw 05/06/13 National
Aveo Cuts Staff, Announces 3rd Quarter Loss 10/31/12 Boston
Bayer, Onyx Cancer Drug Wins FDA Approval Ahead of Schedule 09/27/12 San Francisco
Kinsella Redux: Charting a Way Back for Life Sciences Startups 09/27/12 San Diego
Exelixis and Onyx Await Their Cancer-Drug Fates 09/18/12 San Francisco
Aveo Shares Fall as FDA Questions Cancer Drug Survival Trend 08/02/12 Boston
Bayer Oncology Dubs ASCO “Turning Point” for Cancer Efforts 06/06/12 New York
Genzyme’s Termeer Joins Aveo Board 04/12/11 Boston
Merck Bails on Seattle, Gates Foundation Backs Far-Out Ideas, Zymo Drug Shows Promise & More Seattle-Area Life Sciences News 10/23/08 Seattle
ZymoGenetics’ Kidney Cancer Drug, Taken with Nexavar, Shrinks Tumors in Relapsed Patients 10/22/08 Seattle
Page 1 of 1